Global Epidemiology of Tuberculosis: Morbidity and Mortality of a Worldwide Epidemic

JAMA: The Journal of the American Medical Association

Volumn 273, Issue 3, 1995, Pages 220-226

  Raviglione, Mario C ^a   Kochi, Arata ^a   Snider, Dixie E ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; CANADA; DEVELOPING COUNTRY; EUROPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SOUTHEAST ASIA; TUBERCULOSIS; UNITED STATES;

DATA COLLECTION; DEVELOPING COUNTRIES; DISEASE NOTIFICATION; DISEASE OUTBREAKS; HIV INFECTIONS; HUMAN; INCIDENCE; MORBIDITY; PREVALENCE; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH;

EID: 0028889845     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1995.03520270054031     Document Type: Article

References (81)

1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ. 1994;72:213-220.
2. Styblo K, Rouillon A. Estimated global incidence of smear-positive pulmonary tuberculosis: unreliability of officially reported figures on tuberculosis. Bull Int Union Tuberc Lung Dis. 1981;56:118-126.
3. Styblo K, Meijer J, Sutherland I. The transmission of tubercle bacilli: its trend in a human population. Bull Int Union Tuberc Lung Dis. 1969;42: 5-104.
4. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res. 1976; 19:1-63.
5. Styblo K. The relationship between the risk of tuberculous infection and the risk of developing infectious tuberculosis. Bull Int Union Tuberc Lung Dis. 1986;60:117-119.
6. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention, and cost. Bull Int Union Tuberc Lung Dis. 1990;65:6-24.
7. Cauthen GM, Pio A, ten Dam HG. Annual Risk of Tuberculous Infection. Geneva, Switzerland: World Health Organization; 1988. Publication WHO/ TB/88.154.
8. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ. 1992;70:149-159.
9. Tuberculosis Programme, World Health Organization. Tuberculosis Notification Update: December 1993. Geneva, Switzerland: World Health Organization; 1994. Publication WHO/TB/94.175.
10. The World Bank. World Development Report 1993: Investing in Health. New York, NY: Oxford University Press; 1993:1-225.
11. Raviglione MC, Sudre P, Rieder HL, et al. Secular trends of tuberculosis in western Europe. Bull World Health Organ. 1993;71:297-306.
12. Raviglione MC, Sudre P, Esteves K, et al. Tuberculosis—western Europe, 1974-1991. MMWR Morb Mortal Wkly Rep. 1993;42:628-631.
13. Raviglione MC, Rieder HL, Styblo K, et al. Tuberculosis trends in eastern Europe and the former USSR. Tuberc Lung Dis. 1994;75:400-416.
14. Statistics Canada, Canadian Centre for Health Information. Tuberculosis Statistics 1991. Ottawa, Ontario: Canadian Centre for Health Information; 1993. Catalog 82.220.
15. Centers for Disease Control and Prevention. Tuberculosis Statistics in the United States, 1991. Atlanta, Ga: Centers for Disease Control and Prevention; 1993.
16. Hargreaves J. Tuberculosis notifications in Australia, 1992. Commun Dis Intelligence. 1994;18:330-337.
17. Drolet GJ. Present trend of case fatality rates in tuberculosis. Am Rev Tuberc. 1938;37:125-151.
18. Lindhart M. The Statistics of Pulmonary Tuberculosis in Denmark, 1925-1934. Copenhagen, Denmark: E Munksgaard; 1939.
19. Humphries MJ, Byfield SP, Darbyshire JD, et al. Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales. Br J Dis Chest. 1984;78:149-158.
20. National Tuberculosis Institute, Bangalore. Tuberculosis in a rural population of India: a five-year epidemiological study. Bull World Health Organ. 1974;51:473-488.
21. Springett VH. Ten-year results during the introduction of chemotherapy for tuberculosis. Tubercle. 1971;52:73-87.
22. Cullinan P, Meredith SK. Deaths in adults with notified pulmonary tuberculosis 1983-5. Thorax. 1991;46:347-350.
23. World Health Organization. Childhood Tuberculosis and BCG Vaccine: EPI Update Supplement. Geneva, Switzerland: World Health Organization; 1989.
24. Rieder HL, Cauthen GM, Comstock GW, Snider DE. Epidemiology of tuberculosis in the United States. Epidemiol Rev. 1989;11:79-98.
25. World Health Organization, Global Programme on AIDS. The current global situation of the HIV/ AIDS pandemic. Wkly Epidemiol Rec. 1994;69:189-196.
26. Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuberc Lung Dis. 1992;73:311-321.
27. Eriki PP, Okwera A, Aisu T, et al. The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda. Am Rev Respir Dis. 1991;143:185-187.
28. Aisu T, Raviglione MC, Narain JP, et al. Monitoring HIV-associated tuberculosis in Uganda. In: Program and abstracts of the World Congress on Tuberculosis; November 16-19, 1992; Bethesda, Md. Abstract 43D.
29. Elliott AM, Luo N, Tembo G, et al. Impact of HIV on tuberculosis in Zambia: a cross sectional study. BMJ. 1990;301:412-415.
30. De Cock KM, Gnaore E, Adjorlolo G, et al. Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast. BMJ. 1991;302: 496-499.
31. Chum HL, Graf P, O'Brien RJ, et al. The impact of HIV infection on tuberculosis in Tanzania. In: Program and abstracts of the World Congress on Tuberculosis; November 16-19, 1992; Bethesda, Md. Abstract 41B.
32. Clermont HC, Chaisson RE, Davis HA, et al. HIV-1 infection in adult tuberculosis patients in Cité Soleil, Haiti. In: Program and abstracts of the Sixth International Conference on AIDS; June 20-24, 1990; San Francisco, Calif. Abstract ThB 490.
33. Kritski AL, Werneck-Barroso E, Armandas Vieira M, et al. HIV infection in 567 active pulmonary tuberculosis patients in Brazil. J Acquir Immune Defic Syndr. 1993;6:1008-1012.
34. Payanandana V, Bamrungtrakul T, Konjanart S, Sriyabhaya N. Report of an Internal Evaluation of the National Tuberculosis Programme, Thailand, 1993. Bangkok, Thailand: Tuberculosis Division, Department of Communicable Disease Control, Ministry of Public Health; 1993.
35. Ibopishak Singh I. HIV infection amongst tuberculosis patients at tuberculosis hospital, Chingeirong, Manipur. In: Program and abstracts of the 17th Eastern Regional Conference on Tuberculosis and Respiratory Diseases of the IUATLD, Eastern Region; November 1-4, 1993; Bangkok, Thailand. Abstract OP 48.
36. Mohanty KC, Sundarani RM, Pasi RB. Changing trend of HIV infection in tuberculosis and pulmonary diseases patients, since 1988, at Bombay. In: Program and abstracts of the 17th Eastern Regional Conference on Tuberculosis and Respiratory Diseases of the IUATLD, Eastern Region; November 1-4, 1993; Bangkok, Thailand. Abstract OP 49.
37. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320:545-550.
38. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Shoenbaum EE. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA. 1992;268:504-509.
39. Allen S, Batungwanayo J, Kerlikowske K, et al. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Rev Respir Dis. 1992;146:1439-1444.
40. Guelar A, Gatell JM, Verdejo J, et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS. 1993;7:1345-1349.
41. Girardi E, Antonucci G, Ippolito G, et al. High incidence of tuberculosis in tuberculin positive and in anergic HIV-infected persons: a cohort study. In: Program and abstracts of the Ninth International Conference on AIDS/HIV STD World Congress; June 6-11, 1993; Berlin, Germany. Abstract PO 071153.
42. Bamrungtrakul T, Akarasewi P, Viriyakittja D. Trends of HIV-1 coinfection among tuberculosis patients, Thailand, 1989-1992. In: Program and abstracts of the 17th Eastern Regional Conference on Tuberculosis and Respiratory Diseases of the IUATLD, Eastern Region; November 1-4, 1993; Bangkok, Thailand. Abstract S-2(3).
43. Mbaga JM, Pallangyo KJ, Bakari M, Aris EA. Survival time of patients with acquired immunodeficiency syndrome: experience with 274 patients in Dar-Es-Salaam. East Afr Med J. 1990;67:95-99.
44. Lucas SB, Nounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a West African city. AIDS. 1993;7:1569-1579.
45. McLeod DT, Neill P, Robertson W, et al. Pulmonary diseases in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa. Trans R Soc Trop Med Hyg. 1989;83:691-697.
46. Pretti Dalcolmo M, Kritski AL. Tuberculosis y co-infección por VIH. Revista Argentina Torax. 1993;54:29-34.
47. Jessurum J, Angeles-Angeles A, Gasman N. Comparative demographic and autopsy findings in acquired immunodeficiency syndrome in two Mexican populations. J Acquir Immune Defic Syndr. 1990;3:579-583.
48. Pape JW, Liautaud B, Thomas F, et al. The acquired immunodeficiency syndrome in Haiti. Ann Intern Med. 1985;103:674-678.
49. Kaur A, Babu PG, Jacob M, et al. Clinical and laboratory profile of AIDS in India. J Acquir Immune Defic Syndr. 1992;5:883-889.
50. Tansuphaswasdikul S. Thai experiences on the diagnostic approaches and management of pulmonary complications in HIV infection. Proceedings of the 17th Eastern Regional Conference on Tuberculosis and Respiratory Diseases of the IUATLD, Eastern Region; November 1-4, 1993; Bangkok, Thailand. Abstract S-2(4).
51. Dubos R, Dubos J. The White Plague: Tuberculosis, Man, and Society. New Brunswick, NJ: Rutgers University Press; 1987.
52. Centers for Disease Control and Prevention. Expanded tuberculosis surveillance and tuberculosis morbidity—United States, 1993. MMWR Morb Mortal Wkly Rep. 1994;43:361-366.
53. Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA. 1994;272:535-539.
54. Onorato I, McCombs S, Morgan M, McCray E. HIV infection in patients attending tuberculosis clinics, United States, 1988-1992. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; October 17-20, 1993; New Orleans, La. Abstract 1363.
55. Snider D, Dooley S. Nosocomial tuberculosis in the AIDS era with an emphasis on multidrug-resistant disease. Heart Lung. 1993;22:365-369.
56. Centers for Disease Control. Prevention and control of tuberculosis in correctional institutions: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1989;38:313-325.
57. Centers for Disease Control. Prevention and control of tuberculosis among homeless persons. MMWR Morb Mortal Wkly Rep. 1992;41(RR-5):13-23.
58. Daley C, Small P, Schecter G, et al. An outbreak of tuberculosis with accelerated progression among persons with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphism. N Engl J Med. 1992;326:231-235.
59. Centers for Disease Control. Prevention and control of tuberculosis in facilities providing long-term care to the elderly. MMWR Morb Mortal Wkly Rep. 1990;39(RR-10):7-20.
60. Centers for Disease Control. Crack cocaine use among persons with tuberculosis—Contra Costa County, California, 1987-1990. MMWR Morb Mortal Wkly Rep. 1991;40:485-489.
61. Huret B, Haury B, Moyse C. Les cas de tuberculose déclarés en France en 1992. Bulletin Epidémiologique Hebdomadaire. 1993;52:243-245.
62. Office Fédéral de la Santé Publique. La tuberculose en Suisse, 1988-1992. Bulletin de l'Office Fédéral de la Santé Publique. 1993;41:739-745.
63. Didilescu C, Marica C. Tuberculoza in Romania: Breviar Epidemiologic [Romanian]. Bucharest, Romania: Curtea Veche SRL; 1993.
64. Monno L, Angarano G, Carbonara S, et al. Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients. Lancet. 1991;337:852.
65. Bouvet E. Transmission nosocomiale de tuberculose multirésistante parmi les patients infectés par le VIH: En France, à Paris. Bulletin Epidémiologique Hebdomadaire. 1991;45:196-197.
66. Schwoebel V, Papillon F, Haeghebart S, et al. Surveillance de la tuberculose à bacilles multirésistants en 1992. Bulletin Epidémiologique Hebdomadaire. 1993;50:235-236.
67. Warburton ARE, Jenkins PA, Waight PA, Watson JM. Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales. Commun Dis Rep. 1993;3:R175-R179.
68. Kochi A, Vareldzis B, Styblo K. Multidrug-resistant tuberculosis and its control. Res Microbiol. 1993;144:104-110.
69. Jain NK. Drug resistance in India: a tragedy in the making. Indian J Tuberc. 1992;39:145-148.
70. Dolin PJ, Raviglione MC, Kochi A. A Review of Current Epidemiological Data and Estimation of Future Tuberculosis Incidence and Mortality. Geneva, Switzerland: World Health Organization; 1993. Publication WHO/TB/93.173.
71. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med. 1994;330:1703-1709.
72. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiological methods. N Engl J Med. 1994;330:1710-1716.
73. Hamburg MA, Frieden TR. Tuberculosis transmission in the 1990s. N Engl J Med. 1994;330:1750-1751.
74. Dolin PJ, Raviglione MC, Kochi A. Estimates of future global tuberculosis morbidity and mortality. MMWR Morb Mortal Wkly Rep. 1993;42:961-964.
75. Di Perri G, Cruciani M, Danzi MC, et al. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989;2:1502-1504.
76. Goble M, Iseman MD, Madsen LA, et al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993;328:527-532.
77. Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993;328:521-526.
78. World Health Organization. WHO Tuberculosis Programme: Framework for Effective Tuberculosis Control. Geneva, Switzerland: World Health Organization; 1994. Publication WHO/TB/94.179.
79. Enarson D. Principles of IUATLD collaborative tuberculosis programmes. Bull Int Union Tuberc Lung Dis. 1991;66:195-200.
80. World Health Assembly. Report of the 44th World Health Assembly, Tuberculosis Control Programme. Geneva, Switzerland: World Health Assembly; May 13, 1991. Resolution WHA 44.8.
81. Hong YP, Kim SJ, Kwon DW et al. The sixth Nationwide Tuberculosis Prevalence Survey in Korea, 1990. Tuberc Lung Dis. 1993;74:323-331.